Nitromemantine

Nitromemantine is a derivative of Memantine with enhanced neuroprotective effects. It is a second-generation NMDA receptor antagonist that is designed to treat neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Nitromemantine works by blocking extra-synaptic NMDA receptors, which are associated with neurodegeneration.

Mechanism of Action[edit | edit source]

Nitromemantine is a derivative of memantine, which is a non-competitive NMDA receptor antagonist. Nitromemantine has a nitro group added to the memantine molecule, which enhances its neuroprotective effects. The nitro group allows nitromemantine to preferentially block extra-synaptic NMDA receptors, which are associated with neurodegeneration, while sparing synaptic NMDA receptors, which are necessary for normal neuronal function.

Clinical Uses[edit | edit source]

Nitromemantine is currently being investigated for its potential use in the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. It is believed that by blocking extra-synaptic NMDA receptors, nitromemantine can prevent the neurodegeneration associated with these diseases.

Side Effects[edit | edit source]

As nitromemantine is still in the experimental stages, its side effects are not yet fully known. However, as it is a derivative of memantine, it is possible that it may have similar side effects, which can include dizziness, confusion, and headache.

See Also[edit | edit source]

Nitromemantine Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.